Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Results Details (195)

SortShow
Name Institution Why
Mary-Ellen Taplin, M.D.Dana-Farber Cancer Institute Why?
Matthew Raymond Smith, M.D., Ph.D.Massachusetts General Hospital Why?
Christopher J Sweeney, M.B.,B.S.Dana-Farber Cancer Institute Why?
Glenn J. Bubley, M.D.Beth Israel Deaconess Medical Center Why?
Philip Kantoff, M.D.Brigham and Women's Hospital Why?
Joaquin Bellmunt Molins, M.D.Beth Israel Deaconess Medical Center Why?
Adam Kibel, M.D.Brigham and Women's Hospital Why?
Steven Paul Balk, Ph.D., M.D.Beth Israel Deaconess Medical Center Why?
Guru Sonpavde, M.B.,B.S.Dana-Farber Cancer Institute Why?
Irving D. Kaplan, M.D.Beth Israel Deaconess Medical Center Why?
Andreas Varkaris, Ph.D., M.D.Massachusetts General Hospital Why?
Xiao Wei, M.D.Dana-Farber Cancer Institute Why?
Hanny Al-Samkari, M.D.Massachusetts General Hospital Why?
Jean Marie Connors, M.D.Brigham and Women's Hospital Why?
Li Jia, Ph.D., B.M.Brigham and Women's Hospital Why?
Per Page    Page  of 13last Nextnext
Prev
Search Criteria
  • Phenylthiohydantoin
Click "Why?" to see why a person matched the search.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.